DOCUMENTS RELATED TO 15TH ANNUAL GENERAL MEETING
- Memorandum of Association
- Article of Association
- Newspaper Clipping-English
- Newspaper Clipping-Hindi
- Voting Results
- Transcript
SHAREHOLDERS MEETING NOTICES
- Notice of Shareholders Meeting to be held on 28.09.2018
- Notice of Shareholders Meeting to be held on 28.06.2019
- Notice of Shareholding Meeting to be held on 22.04.2019
- Notice of Shareholding Meeting to be held on 30.09.2019
- Notice of Annual General Meeting to be held on 30.09.2020
BETA POLICIES
- CSR POLICY
- Code of Conduct
- Policy on Archival of Documents
- Policy on Criteria for Determining Materiality of Events
- Policy on Preservation of Documents
- Policy on Related Party Transaction
- Policy on Remuneration Nomination and Board Diversity
- Policy for determining Material Subsidiaries
BOARD MEETING NOTICES
- Notice of Board Meeting to be held on 17.08.2018
- Notice of Board Meeting to be held on 08.05.2018
- Notice of Board Meeting to be held on 4th may 2018
- Notice of Board Meeting to be held on 20.04.2018
- Notice of Board Meeting to be held on 14.03.2018
- Notice of Board Meeting to be held on 03.01.2018
- Notice of Board Meeting to be held on 01.08.2019
- Notice of Board Meeting to be held on 31.08.2019
- Notice of Board Meeting to be held on 27.09.2019
- Notice of Board Meeting to be held on 23.10.2019
- Notice of Board Meeting to be held on 08.11.2019
- Notice of Board Meeting to be held on 22.11.2019
- Notice of Board Meeting to be held on 15.01.2020
- Notice of Board Meeting to be held on 24.01.2020
- Notice of Board Meeting to be held on 28.05.2020
- Notice of Board Meeting to be held on 17.06.2020
- Notice of Board Meeting to be held on 31.08.2020
- Notice of Board Meeting to be held on 19.10.2020
- Notice of Board Meeting to be held on 24.09.2020
Financial Results
- Financial Results 31.03.2018
- Financial Results 30.09.2018
- Financial Results 31.03.2019
- Financial Results 30.09.2019
- Financial Results 31.03.2020
- Financial Results 30.09.2020
Concall Invitation
CERTIFICATE UNDER REGULATION 40(9) OF SEBI(LODR) REGULATION
- Certificate under regulation 40(9) of sebi(lobr) regulation
- Certificate under regulation 40(9) of sebi(lobr) regulation 30.09.2018
- Certificate under regulation 40(9) of sebi(lobr) regulation 31.03.2019
- Certificate under regulation 40(9) of sebi(lobr) regulation 30.09.2019
- Certificate under regulation 40(9) of sebi(lobr) regulation 31.03.2020
- Certificate under regulation 40(9) of sebi(lobr) regulation 30.09.2020
COMPLIANCE CERTIFICATE UNDER 7(3) OF SEBI(LODR) REGULATION
- Compliance certificate under regulation 7 (3) of sebi(lobr) regulation 31.03.2018
- Compliance certificate under regulation 7(3) of sebi(lobr) regulation 30.09.2018
- Compliance certificate under regulation 7(3) of sebi(lobr) regulation 31.03.2019
- Compliance certificate under regulation 7(3) of sebi(lobr) regulation 30.09.2019
- Compliance certificate under regulation 7(3) of sebi(lobr) regulation 31.03.2020
- Compliance certificate under regulation 7(3) of sebi(lobr) regulation 30.09.2020
COMPOSITION OF COMMITTEES
DISCLOSURE UNDER REGULATION 30(10 & 30(2) OF SEBI (SAST) REGULATION
- Disclosure under Regulation 30(1) and 30(2) of SEBI (SAST) Regulation 31.03.2018
- Disclosure under Regulation 30(1) and 30(2) of SEBI (SAST) Regulation 31.03.2019
- Disclosure under Regulation 30(1) and 30(2) of SEBI (SAST) Regulation 31.03.2020
INVESTORS MEET
- Intimation of Investor Meet 09.01.2018
- Intimation of Investor Meet 07.03.2018
- Intimation of Investor Meet 14.06.2018
- Intimation of Investor Meet 06.12.2018
- Intimation of Investor Meet 29.12.2018
- Intimation of Investor Meet 24.01.2019
- Intimation of Investor Meet 24.04.2019
OUTCOME OF BOARD MEETING
- Outcome of Board Meeting 08.05.2018
- Outcome of Board Meeting 20.04.2018
- Outcome of Board Meeting 14.03.2018
- Outcome of Board Meeting 03.01.2018
- Outcome of Board Meeting 31.08.2019
- Outcome of Board Meeting 23.10.2019
- Outcome of Board Meeting 28.05.2020
- Outcome of Board Meeting 17.06.2020
- Outcome of Board Meeting 06.07.2020
- Outcome of Board Meeting 31.08.2020
- Outcome of Board meeting 19.10.2020
- Outcome of Board meeting 24.09.2020
SHARE HOLDING PATTERN
- Shareholding Pattern as on 31.12.2020
- Shareholding Pattern as on 30.09.2020
- Shareholding Pattern as on 30.06.2020
- Share holding Pattern ason 31.03.2020
- Share holding Pattern ason 30.09.2019
- Shareholding Pattern as on 31.03.2019
- Shareholding Pattern as on 30.09.2018
- Share holding Pattern ason 31.03.2018
- Share holding Pattern ason 11.10.2017
ANNUAL REPORT
BETA’S UPDATES
- Update on Beta Uzbekistan Subsidiary 16.08.2019
- Update on Beta Uzbekistan Subsidiary 12.03.2019
- Update regarding the Beta Drugs’ Uzbekistan Plant 31.01.2019
- lmpact of COVID 19 pandemic on the business of the Company 23.06.2020
- Received 20 product registration certificates from Ministry of Health Uzbekistan 27.04.2020
- New Product Launches 12.06.2020
- Launch of Axitinib by Beta Drugs Limited 04.09.2020
- Intimation of Incorporatipn of Subsidiary in Republic of Uzbekistan 18.10.2018
- Intimation of Incorporation of a Wholly Owned Subsidiary Company 11.10.2018
- International Plant Approvals 15.11.2019
- Beta Drugs Baddi facility manufacturing oncology products receives philippines GMP Certification 12.07.2018
- Intimation of Acquisition of 100% shares of Adley lab limited 25.10.2019
- Azer News Beta 20.10.2018
- Acquisition of Adley Formulations 05.11.2018
- Launch of Lenvatinib and Enzalutamide
Contact For Investors Grevience
CONTACT INFORMATION OF THE DESIGNATED OFFICIALS OF THE LISTED ENTITY WHO ARE RESPONSIBLE FOR ASSISTING AND HANDLING INVESTOR GRIEVANCES AND EMAIL ADDRESS FOR GRIEVANCE REDRESSAL AND OTHER RELEVANT DETAILS
*At the Registrar and Transfer Agent of the Company:
Link Intime India Pvt. Ltd.,
C-101, 247 Park, L.B.S Marg,
Vikhroli West Mumbai,-400 083
Tel: +022-49186200, Fax: 022-49186195
E-mail : betadrugs.ipo@linkintime.co.in
Website: www.linkintime.co.in
*At the Company: Company Secretary Beta Drugs Limited Corporate Office:
SCO-184, Sector 5 Panchkula 134114.
Tel.: +91-172-2585481
E-mail: cs@betadrugslimited.com
Website: www.betadrugslimited.com